Meeting description
This three and a half day meeting offers clinicians an academic environment to learn about the latest research, network with peers (for informal learning experiences), and discuss current issues in treating women with gynecologic malignancies, specifically gestational trophoblastic disease. Some of the key clinical areas to be presented include:

  • Pathophysiology of gestational trophoblastic disease (GTD)
  • Diagnosis and management of hydatidiform mole
  • Diagnosis and staging of gestational trophoblastic neoplasia (GTN)
  • Guidelines for choosing the most appropiate single-agent chemotherapy for low-risk GTN
  • Multi-modal management of high-risk GTN
  • Reasons for GTN treatment success and failure
  • Diagnosis and management of placental site trophoblastic tumor

Meeting objectives
As a result of attending this meeting, participants will be able to:

  • Diagnose and manage molar pregnancy and define indications for treatment of postmolar GTN
  • Choose the most appropriate single-agent chemotherapy for low-risk GTN
  • Understand the primary treatment of high-risk GTN
  • Determine the role of surgery in the management of high-risk GTN
  • Decide when and what to use for secondary chemotherapy of resistant GTN
  • Learn the best management of placental site trophoblastic tumor
  • Appreciate the impact of treatment for GTN on reproductive outcomes
  • Recognize the benefits of utilizing trophoblastic disease referral centers
  • Comprehend molecular pathways and potential targets for therapy associated with molar pregnancies and GTN

Target audience

  • gynecologic oncologists
  • medical oncologists
  • radiation oncologists
  • obstetrician/gynecologists
  • surgical oncologists
  • fellow and residents
  • research scientists
  • nurses
  • nurse practitioners
  • physician assistants
  • and others involved in the care of patients with gyncologic malignancies